Journal articleJ Med Chem2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.
- Journal
- J Med Chem
- Published
- 6 March 2019
- Citations
- 33
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Kras-Induced Cellular Plasticity in Pancreatic Cancer R01CA124586↗
- Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinatio… R01CA167291↗
- Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease R01CA211098↗
- Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis U01HL143403↗